Vardenafil is effective and well-tolerated for treating erectile dysfunction in a broad population of men, irrespective of age

François Giuliano, Craig Donatucci, Francesco Montorsi, Stephen Auerbach, Gary Karlin, Christiane Norenberg, Martin Homering, Thomas Segerson, Ian Eardley

Research output: Contribution to journalArticlepeer-review

Abstract

OBJECTIVES: To assess the efficacy and safety of vardenafil in the treatment of erectile dysfunction (ED) in men of different age groups. PATIENTS AND METHODS: In a retrospective pooled subgroup analysis of randomized, double-blind, placebo-controlled studies, men from the general population with ED received either placebo or vardenafil 5, 10 or 20 mg over 12 weeks. Efficacy variables included the erectile function (EF) domain score from The International Index of Erectile Function, diary response rates to questions on vaginal penetration and maintenance of erection, and positive responses to the Global Assessment Question (GAQ) 'Has the treatment you have been taking over the past 4 weeks improved your erections?'. The 1385 men were grouped by age (

Original languageEnglish
Pages (from-to)110-116
Number of pages7
JournalBJU International
Volume95
Issue number1
DOIs
Publication statusPublished - Jan 2005

Keywords

  • Elderly
  • Erectile dysfunction
  • Oral PDE-5 inhibitors
  • Placebo-controlled clinical trial

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Vardenafil is effective and well-tolerated for treating erectile dysfunction in a broad population of men, irrespective of age'. Together they form a unique fingerprint.

Cite this